Medtronic is a good defensive pick for sector - Barron's
NEW YORK, Feb 28 (Reuters) - Medical equipment maker Medtronic Plc is a solid pick in its sector and will likely deliver a smoother ride to earnings growth than competitors, weekly investment newspaper Barron's reported in its Feb. 29 edition.
Medtronic is growing faster than Johnson & Johnson and has a broader product portfolio and more revenue than Boston Scientific Corp, Barron's reported.
It also has other possible earnings growth built into its $50 billion acquisition of Covidien, which closed last year. That could enable it to cut costs, consolidate manufacturing and push suppliers for price breaks, the newspaper said.
(Reporting by Caroline Humer; Editing by Cynthia Osterman)
Terms and Privacy Policy